Today's edition · Wednesday, November 18, 2026
Every story verifiedNo politics. Ever.No pop-ups
TodayLocalWorldHeroesAnimalsScienceCommunityHealth & TechMapQuizKindnessAnnouncementsKidsTopicsExplainersOn this dayCalendarGood NeighborHometown Heroes

TodayHealth & TechNorth Carolina

Health & TechWinston-Salem, North Carolina

Early study: all 10 wounds closed with a placental cell therapy

In a first-in-human safety study from Wake Forest, all 10 stubborn diabetic foot ulcers fully closed within six months. It is not a cure.

Verified · Source: Atrium Health Wake Forest BaptistNov 12, 2026 · 1 min read
How to help
An empty biosafety cabinet in a laboratory
Illustrative photo of a laboratory cabinet. This is not the Wake Forest study, and it does not show a wound or a patient. Ajay Kumar Chaurasiya / Wikimedia Commons · CC BY-SA 4.0

Read the original

The reporting lives at Atrium Health Wake Forest Baptist. Our summary is checked against it, and we link it on every story.

A first-in-human study from the Wake Forest Institute for Regenerative Medicine tested a placental cell therapy on stubborn diabetic foot ulcers, Atrium Health Wake Forest Baptist reported. The study, published in Stem Cells Translational Medicine, included 10 patients. All 10 wounds fully closed within six months. Researchers reported no treatment-related serious adverse events.

This is an early safety study. Larger controlled trials are the next step. It is not a cure. The work is based in Winston-Salem, and ten patients is the whole group in this pilot.

More good news

Other stories in the same neighborhood of kindness.